Literature DB >> 18828973

Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.

Saadia Sherazi1, James P Daubert, Robert C Block, Vinodh Jeevanantham, Khalid Abdel-Gadir, Michael R DiSalle, James M Haley, Abrar H Shah.   

Abstract

Clinical guidance is deficient regarding deactivation of implantable cardioverter-defibrillators (ICDs) in patients with terminal illnesses. We hypothesized that many physicians are apprehensive about discussing ICD deactivation with their dying patients. Thus, we conducted an anonymous survey of all the physicians in the Department of Medicine at Unity Health System in Rochester, NY. The survey collected information about the knowledge and preferences of these physicians regarding the medical, ethical, and legal issues involved in caring for patients with an ICD and terminal illness. Of the 204 surveys distributed, 87 (43%) were returned. Among the physicians who responded, 64 (74%) reported experience caring for a patient with an ICD and terminal illness. Forty physicians (46%) either thought it was illegal or were not sure if it was legal to deactivate an ICD in these circumstances. However, if reassured about the legality of discontinuing ICD therapy, 79 (91%) of these same respondents said that they would be willing to discuss voluntary ICD deactivation with their dying patients. With increased knowledge about managing the withdrawal of this potentially life-prolonging therapy, physicians are likely to become more skilled at caring for dying patients with an ICD.

Entities:  

Mesh:

Year:  2008        PMID: 18828973     DOI: 10.4065/83.10.1139

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  20 in total

1.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  [Implantable cardioverter-defibrillator at the end of life].

Authors:  D Pfeiffer; A Hagendorff; C Kühne; S Reinhardt; N Klein
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

Review 3.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

Review 4.  [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Authors:  K-H Ladwig; N F Ischinger; J Ronel; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-09

5.  [Dying with/despite a pacemaker].

Authors:  S Reith; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-01-04       Impact factor: 0.840

6.  "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.

Authors:  Daniel B Kramer; Abigale L Ottenberg; Samantha Gerhardson; Luke A Mueller; Sharon R Kaufman; Barbara A Koenig; Paul S Mueller
Journal:  J Interv Card Electrophysiol       Date:  2011-07-30       Impact factor: 1.900

7.  End of life care in advanced heart failure.

Authors:  Eldrin F Lewis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-02

Review 8.  [Ethics in intensive care and euthanasia : With respect to inactivating defibrillators at the end of life in terminally ill patients].

Authors:  H-J Trappe
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-17       Impact factor: 0.840

Review 9.  The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Authors:  Jörg Carlsson; Norbert W Paul; Matthias Dann; Jörg Neuzner; Dietrich Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2012-08-20       Impact factor: 5.594

Review 10.  Deactivation of pacemakers and implantable cardioverter-defibrillators.

Authors:  Daniel B Kramer; Susan L Mitchell; Dan W Brock
Journal:  Prog Cardiovasc Dis       Date:  2012 Nov-Dec       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.